Please enter your login details

News & Events

Dulaglutide (Trulicity) - NICE Evidence Summary

( 2nd July 2015)


NICE has published an evidence summary on new medicines:

Type 2 diabetes: dulaglutide (Trulicity) (ESNM59) <> .  Evidence summaries: new medicines' provide a summary of the published evidence for selected new medicines, or for existing medicines with new indications or formulations, that are considered to be of significance to the NHS. The strengths and weaknesses of the relevant evidence are critically reviewed within the summary, but the summaries are not formal NICE guidance.